151 related articles for article (PubMed ID: 31047931)
1. Natural constituents of St. John's Wort inhibit the proteolytic activity of human thrombin.
Wei LH; Chen TR; Fang HB; Jin Q; Zhang SJ; Hou J; Yu Y; Dou TY; Cao YF; Guo WZ; Ge GB
Int J Biol Macromol; 2019 Aug; 134():622-630. PubMed ID: 31047931
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pancreatic lipase by the constituents in St. John's Wort: In vitro and in silico investigations.
Hou XD; Guan XQ; Cao YF; Weng ZM; Hu Q; Liu HB; Jia SN; Zang SZ; Zhou Q; Yang L; Ge GB; Hou J
Int J Biol Macromol; 2020 Feb; 145():620-633. PubMed ID: 31883893
[TBL] [Abstract][Full Text] [Related]
3. Biflavones from Ginkgo biloba as inhibitors of human thrombin.
Chen TR; Wei LH; Guan XQ; Huang C; Liu ZY; Wang FJ; Hou J; Jin Q; Liu YF; Wen PH; Zhang SJ; Ge GB; Guo WZ
Bioorg Chem; 2019 Nov; 92():103199. PubMed ID: 31446241
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
5. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
6. Effect of St. John's wort on free radical production.
Hunt EJ; Lester CE; Lester EA; Tackett RL
Life Sci; 2001 Jun; 69(2):181-90. PubMed ID: 11441908
[TBL] [Abstract][Full Text] [Related]
7. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
Schwarz D; Kisselev P; Roots I
Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
[TBL] [Abstract][Full Text] [Related]
8. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
9. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
[TBL] [Abstract][Full Text] [Related]
10. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
11. On the Mechanism of Action of Anti-Inflammatory Activity of Hypericin: An In Silico Study Pointing to the Relevance of Janus Kinases Inhibition.
Dellafiora L; Galaverna G; Cruciani G; Dall'Asta C; Bruni R
Molecules; 2018 Nov; 23(12):. PubMed ID: 30467287
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 17β-estradiol activation by CYP1A1: genotype- and regioselective inhibition by St. John's Wort and several natural polyphenols.
Schwarz D; Kisselev P; Schunck WH; Roots I
Biochim Biophys Acta; 2011 Jan; 1814(1):168-74. PubMed ID: 20883830
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
14. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
15. A high-performance liquid chromatography with electrochemical detection for the determination of total hypericin in extracts of St. John's Wort.
Rückert U; Eggenreich K; Likussar W; Wintersteiger R; Michelitsch A
Phytochem Anal; 2006; 17(3):162-7. PubMed ID: 16749423
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
17. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
18. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding.
Raffa RB
Life Sci; 1998; 62(16):PL265-70. PubMed ID: 9585174
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort.
Williams FB; Sander LC; Wise SA; Girard J
J Chromatogr A; 2006 May; 1115(1-2):93-102. PubMed ID: 16554056
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Nahrstedt A; Butterweck V
J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
